CRH Medical Corp (TSE:CRH) had its price objective lifted by Royal Bank Of Canada from C$7.00 to C$8.50 in a report issued on Monday, StockTargetPrices.com reports. The firm currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 1.67% from the company’s previous close.
A number of other research firms have also commented on CRH. Bloom Burton restated a “buy” rating on shares of CRH Medical Corp in a research note on Friday, October 28th. RBC Capital Markets set a C$6.50 price target on shares of CRH Medical Corp and gave the stock an “outperform” rating in a research note on Thursday, October 6th. Finally, CIBC reiterated an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. CRH Medical Corp currently has a consensus rating of “Buy” and an average price target of C$6.90.
Shares of CRH Medical Corp (TSE:CRH) traded down 9.09% on Monday, reaching $7.60. 804,481 shares of the company were exchanged. CRH Medical Corp has a 52-week low of $2.98 and a 52-week high of $8.48. The company has a market capitalization of $549.68 million and a P/E ratio of 77.55. The stock has a 50 day moving average of $6.74 and a 200-day moving average of $5.26.